Review



antibodies against p-aurka  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Cell Signaling Technology Inc antibodies against p-aurka
    Antibodies Against P Aurka, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against p-aurka/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    antibodies against p-aurka - by Bioz Stars, 2026-02
    90/100 stars

    Images



    Similar Products

    p aurka  (Novus Biologicals)
    92
    Novus Biologicals p aurka
    P Aurka, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p aurka/product/Novus Biologicals
    Average 92 stars, based on 1 article reviews
    p aurka - by Bioz Stars, 2026-02
    92/100 stars
    		  Buy from Supplier
    antibodies against p-aurka  (Cell Signaling Technology Inc)
    90
    Cell Signaling Technology Inc antibodies against p-aurka
    Antibodies Against P Aurka, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against p-aurka/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    antibodies against p-aurka - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    p aurka  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc p aurka
    ( A ) Tumor volumes for CDC PDX models treated with vehicle control ( n = 9 mice) or CDK9 inhibitor LDC000067 (LDC, n = 10 mice) ( p value = 1.1E-07, two-way ANOVA). Data were presented as the mean ± SD. ( B ) Survival analysis for mice treated with LDC ( n = 10 mice), compared with those treated with vehicle control ( n = 9 mice) ( p value = 3.00E-06, log-rank test). ( C ) Body weight of the CDC1 PDXs. Vehicle control ( n = 9 mice) and LDC ( n = 10 mice). Data were presented as the mean ± SD. ( D ) Ki67, <t>p-AURKA,</t> TPX2, and p-RB1 staining of selected PDX tumors treated with vehicle control or LDC. ( E – H ) Ki67 positive cells per area, a staining score of p-AURKA, TPX2, and p-RB1 respectively, comparing PDX tumors treated with vehicle control or LDC ( n = 5 mice, two-sided t -test, equal variance). .
    P Aurka, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p aurka/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    p aurka - by Bioz Stars, 2026-02
    96/100 stars
    		  Buy from Supplier
    antibody against phospho(p)-aurka/b/c #2914  (Cell Signaling Technology Inc)
    90
    Cell Signaling Technology Inc antibody against phospho(p)-aurka/b/c #2914
    ( A ) Tumor volumes for CDC PDX models treated with vehicle control ( n = 9 mice) or CDK9 inhibitor LDC000067 (LDC, n = 10 mice) ( p value = 1.1E-07, two-way ANOVA). Data were presented as the mean ± SD. ( B ) Survival analysis for mice treated with LDC ( n = 10 mice), compared with those treated with vehicle control ( n = 9 mice) ( p value = 3.00E-06, log-rank test). ( C ) Body weight of the CDC1 PDXs. Vehicle control ( n = 9 mice) and LDC ( n = 10 mice). Data were presented as the mean ± SD. ( D ) Ki67, <t>p-AURKA,</t> TPX2, and p-RB1 staining of selected PDX tumors treated with vehicle control or LDC. ( E – H ) Ki67 positive cells per area, a staining score of p-AURKA, TPX2, and p-RB1 respectively, comparing PDX tumors treated with vehicle control or LDC ( n = 5 mice, two-sided t -test, equal variance). .
    Antibody Against Phospho(P) Aurka/B/C #2914, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibody against phospho(p)-aurka/b/c #2914/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    antibody against phospho(p)-aurka/b/c #2914 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    rabbit monoclonal p aurka thr288  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc rabbit monoclonal p aurka thr288
    ( A ) Tumor volumes for CDC PDX models treated with vehicle control ( n = 9 mice) or CDK9 inhibitor LDC000067 (LDC, n = 10 mice) ( p value = 1.1E-07, two-way ANOVA). Data were presented as the mean ± SD. ( B ) Survival analysis for mice treated with LDC ( n = 10 mice), compared with those treated with vehicle control ( n = 9 mice) ( p value = 3.00E-06, log-rank test). ( C ) Body weight of the CDC1 PDXs. Vehicle control ( n = 9 mice) and LDC ( n = 10 mice). Data were presented as the mean ± SD. ( D ) Ki67, <t>p-AURKA,</t> TPX2, and p-RB1 staining of selected PDX tumors treated with vehicle control or LDC. ( E – H ) Ki67 positive cells per area, a staining score of p-AURKA, TPX2, and p-RB1 respectively, comparing PDX tumors treated with vehicle control or LDC ( n = 5 mice, two-sided t -test, equal variance). .
    Rabbit Monoclonal P Aurka Thr288, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit monoclonal p aurka thr288/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    rabbit monoclonal p aurka thr288 - by Bioz Stars, 2026-02
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    ( A ) Tumor volumes for CDC PDX models treated with vehicle control ( n = 9 mice) or CDK9 inhibitor LDC000067 (LDC, n = 10 mice) ( p value = 1.1E-07, two-way ANOVA). Data were presented as the mean ± SD. ( B ) Survival analysis for mice treated with LDC ( n = 10 mice), compared with those treated with vehicle control ( n = 9 mice) ( p value = 3.00E-06, log-rank test). ( C ) Body weight of the CDC1 PDXs. Vehicle control ( n = 9 mice) and LDC ( n = 10 mice). Data were presented as the mean ± SD. ( D ) Ki67, p-AURKA, TPX2, and p-RB1 staining of selected PDX tumors treated with vehicle control or LDC. ( E – H ) Ki67 positive cells per area, a staining score of p-AURKA, TPX2, and p-RB1 respectively, comparing PDX tumors treated with vehicle control or LDC ( n = 5 mice, two-sided t -test, equal variance). .

    Journal: EMBO Molecular Medicine

    Article Title: Comprehensive molecular characterization of collecting duct carcinoma for therapeutic vulnerability

    doi: 10.1038/s44321-024-00102-5

    Figure Lengend Snippet: ( A ) Tumor volumes for CDC PDX models treated with vehicle control ( n = 9 mice) or CDK9 inhibitor LDC000067 (LDC, n = 10 mice) ( p value = 1.1E-07, two-way ANOVA). Data were presented as the mean ± SD. ( B ) Survival analysis for mice treated with LDC ( n = 10 mice), compared with those treated with vehicle control ( n = 9 mice) ( p value = 3.00E-06, log-rank test). ( C ) Body weight of the CDC1 PDXs. Vehicle control ( n = 9 mice) and LDC ( n = 10 mice). Data were presented as the mean ± SD. ( D ) Ki67, p-AURKA, TPX2, and p-RB1 staining of selected PDX tumors treated with vehicle control or LDC. ( E – H ) Ki67 positive cells per area, a staining score of p-AURKA, TPX2, and p-RB1 respectively, comparing PDX tumors treated with vehicle control or LDC ( n = 5 mice, two-sided t -test, equal variance). .

    Article Snippet: The sections were then incubated with antibodies specific to Ki67 (Zsbio Commerce Store, cat #ZA-0502), p-AURKA (Cell Signaling Technology, cat #3079), TPX2 (Cell Signaling Technology, cat #12245), p-RB1 (Cell Signaling Technology, cat #8180), CK19 (Cell Signaling Technology, cat #13902) and PAX8 (Cell Signaling Technology, cat #28556) at 4 °C overnight, respectively.

    Techniques: Control, Staining

    Reagents and tools table

    Journal: EMBO Molecular Medicine

    Article Title: Comprehensive molecular characterization of collecting duct carcinoma for therapeutic vulnerability

    doi: 10.1038/s44321-024-00102-5

    Figure Lengend Snippet: Reagents and tools table

    Article Snippet: The sections were then incubated with antibodies specific to Ki67 (Zsbio Commerce Store, cat #ZA-0502), p-AURKA (Cell Signaling Technology, cat #3079), TPX2 (Cell Signaling Technology, cat #12245), p-RB1 (Cell Signaling Technology, cat #8180), CK19 (Cell Signaling Technology, cat #13902) and PAX8 (Cell Signaling Technology, cat #28556) at 4 °C overnight, respectively.

    Techniques: Sequencing, Drug discovery, Modification, Saline, cDNA Synthesis, Polymer, Software